Trulieve Cannabis Corp. operates as a cannabis retailer in the United States. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through hom…
Industry Peers
Drug Manufacturers - Specialty & Generic| Headline | Source | Time |
|---|---|---|
Older | ||
 Trulieve Cannabis Q2 Earnings Call Highlights Trulieve Cannabis (NYSE:TRLV) reported second-quarter revenue of $271 million, while outlining plans to expand in Georgia and Texas following changes in medical cannabis regulations and the company’s June listing on the New York Stock Exchange. The company said reported second-quarter results inclu | ||
 Trulieve Cannabis (TRLV) Reports Steeper Losses And Lower Sales, Is The Valuation Discount Justified? Trulieve Cannabis earnings and what changed Trulieve Cannabis (TRLV) reported second quarter 2026 results that drew attention. Sales for the quarter were US$271 million with a net loss of US$406 million, compared with smaller losses and higher sales a year earlier. Over the first half of 2026, sales were US$557.7 million and the company reported a net loss of US$403.6 million. Loss per share from continuing operations increased sharply for both the quarter and six month periods. See our... | ||
 Trulieve Shares Advance After Earnings Beat Despite Revenue Miss Trulieve Cannabis Corp. (NYSE:TRLV) reported stronger-than-expected second-quarter earnings, with investors focusing on improved profitability even though revenue came in slightly below market forecasts. | ||
 Should You Buy, Hold or Sell GTBIF Stock Post Q2 Earnings Release? Green Thumb tops Q2 earnings and sales estimates, but can regulatory catalysts, buybacks and expansion plans outweigh pricing pressure and fierce competition? | ||
Weekly Roundup on the Cannabis Sector & Psychedelic Sector Key Takeaways; Cannabis Sector Trulieve and Green Thumb were Named Among TIME’s America’s Best Companies of 2026 Curaleaf Holdings Options Set to Begin Trading on Montréal Exchange Aurora Cannabis Earned TIME Canada Recognition, As the Company Announced Plans to Strengthen Governance Ahead of Annual Meeting Key Takeaways; Psychedelic Sector Compass Pathways Strengthened Case for FDA […] | MMarket Exclusive | |
 Trulieve CEO Sells $1.2 Million in Stock as Shares Jump 148% in One Year This vertically integrated cannabis operator reported significant insider selling in its latest SEC disclosure. | ||
 Trulieve's NYSE Listing Is Historic. But Is the Stock Still Worth Buying? The listing matters, but fundamentals matter more. | ||
 Jim Cramer on Trulieve Cannabis: “I Think It’s a Terrific Spec” Trulieve Cannabis Corp. (NYSE:TRLV) was among the stocks on which Jim Cramer commented, as he emphasized that SpaceX investors are betting on Elon Musk rather than the company’s earnings. A caller asked for Cramer’s opinion of the company, and in response, he said: Okay, I’ve always liked the brand name. I’ve always felt that it’s […] | IInsider Monkey | |
GTBIF Stock Climbs 17.5% in Three Months: Time to Invest or Cash Out? Green Thumb has surged 17.5% in three months as regulatory progress, Q1 growth and buybacks lift sentiment, but competition and pricing pressure persist. | ||
 The First U.S. Marijuana Stock Is Now Trading on the NYSE. Here's What That Means for Every Cannabis Investor. A major barrier for cannabis stocks just fell. | ||